Happy Health Partners with Biogen with Multiple Sclerosis Patients

Digital Therapeutic Manufacturer HappyPhys Health is partnering with biogenesis-centric pharma company Biogen on a digital engagement and education platform for multiple sclerosis.

The product will include access to the Happiness community for people living with MS, as well as access to neurology providers such as doctors and nurses, mental health professionals, dietitians and rehabilitation professionals. Biogen will contribute to the educational content and resources of patient care.

“This collaboration is one of the many ways we focus on supporting patients wherever they meet them. The combination of biogenesis skills in neuroscience and our commitment to digital health, along with AI and Digital Therapeutic capabilities in HappyPhys Health, will help drive a broader and broader drive.” Experiences that allow patients to feel supported throughout their journey, ”Jason Habecker, head of strategic partnerships and collaboration at Biogen, said in a statement.

“We are excited about the potential of this partnership to provide overall support for the MS community.”

Why it matters

According to According to the National Multiple Sclerosis Society, about one million people in the United States have MS. The disease can cause symptoms such as numbness or tingling, weakness, difficulty walking, vision problems and dizziness.

HappyFi is pitching the collaboration as a way to improve a patient’s care journey and keep them informed about their condition.

Offer Leidner, president of HappyPhys Health, said, “For people living with MS, staying up-to-date with recent treatments, explaining new symptoms or investigating changes in their health may or may not be related to MS. ” Said in a statement.

“We’re providing the MS community with a solution configured to meet their specific needs, as well as the opportunity to engage with experts, receive curated content and discuss disease management with other community members. We’re excited to partner with Biogen.” Their leadership in MS space. “

Greater trend

HappyFi has been in a partnership tier in recent months. At the beginning of this month, the digital therapeutic company said The insurer has announced a partnership with Anthem to focus on women’s health, which will soon be rebranded at Eleven Health.

In March, Happyify entered into an agreement with healthcare and pharmaceutical company Jewelig Pharma to commercialize two of its prescription digital therapies in Asia.

The startup is also recent The Barcelona-based pharma company has launched a digital program for people with psoriasis in Spain, Italy and the United Kingdom as part of a partnership with Almiral. HappyFi closed the ডি 73 million Series D funding round in March 2021.

Biogen is not new to digital health either. In May, it Prescription Digital Therapeutics startup has entered into a licensing agreement with MedRhythms for the development and commercialization of its MR-004 product, which aims to improve the mobility of people with multiple sclerosis.

Leave a Reply

Your email address will not be published.